Flutiform

Flutiform is a combination inhaler containing Fluticasone Propionate and Formoterol Fumarate Dihydrate, used for managing asthma and chronic obstructive pulmonary disease (COPD). This medication helps control symptoms and improve breathing.

Flutiform is primarily used for the maintenance treatment of asthma and COPD. The Fluticasone Propionate component is a corticosteroid that reduces inflammation in the airways, while Formoterol Fumarate Dihydrate is a long-acting beta-agonist that helps relax the muscles around the airways. Together, they work to improve breathing and reduce symptoms such as wheezing, shortness of breath, and coughing. This medication is often prescribed for long-term management rather than for immediate relief of acute symptoms.

Common effects of Flutiform may include throat irritation, hoarseness, and a dry mouth or throat. Some users might experience tremors, headaches, or an increased heart rate. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider.

Flutiform should be used as directed by a healthcare provider. It is important to rinse your mouth with water after each use to reduce the risk of throat irritation and fungal infections. Patients with certain medical conditions, such as heart disease or diabetes, should discuss their health status with their healthcare provider before using this medication. Always follow the prescribed dosage and administration instructions.

Flutiform may interact with other medications, including beta-blockers, which can reduce the effectiveness of the Formoterol component. It is also important to avoid using other long-acting beta-agonists or corticosteroids unless directed by a healthcare provider. Additionally, certain antifungal medications and HIV protease inhibitors can affect the metabolism of Fluticasone Propionate, potentially increasing the risk of side effects.